She wanted Ozempic. Talking to Jia Tolentino in the New Yorker, plastic surgeon Jonathan Kaplan said he thinks Ozempic use is going to tick up among fat people soon specifically, Tolentino writes, fat people who had been struggling with discomfort, with inconvenience, with social pressure all their lives, who might have lately felt encouraged to try to accept their heavier weight. Now, says Kaplan, Theyre no longer going to accept that they should just be happy with the body they have. Ozempic seems to give our body-fascist culture permission to say the quiet part out loud, the quiet things we whisper to one another when we sell Barbie merch: Your body is not enough, you should hate your body, you can fix your body only by suffering and injecting and sacrificing money for its eternal maintenance
Folds and furrows appear
N.KennellyJ
On average, patients experience an 8-10% reduction in body weight, though individual results may vary
Nevertheless, based on the promising pre-clinical and early-phase clinical trial findings in the colorectal cancer setting [12, 13, 32, 151], a Chinese phase III trial aiming to evaluate the effectiveness of combing high dose IV VitC (1.5 g/kg) with FOLOX +/ bevacizumab versus treatment with FOLFOX +/ bevacizumab alone as first-line therapy in patients with recurrent or advanced colorectal cancer is currently ongoing (ClinicalTrials.gov Identifier: NCT02969681, Table 3, recruiting status unclear)
